Literature DB >> 25440530

Histological studies of neuroprotective effects of Curcuma longa Linn. on neuronal loss induced by dexamethasone treatment in the rat hippocampus.

Acharaporn Issuriya1, Ekkasit Kumarnsit2, Chatchai Wattanapiromsakul3, Uraporn Vongvatcharanon4.   

Abstract

Long term exposure to dexamethasone (Dx) is associated with brain damage especially in the hippocampus via the oxidative stress pathway. Previously, an ethanolic extract from Curcuma longa Linn. (CL) containing the curcumin constituent has been reported to produce antioxidant effects. However, its neuroprotective property on brain histology has remained unexplored. This study has examined the effects of a CL extract on the densities of cresyl violet positive neurons and glial fibrillary acidic protein immunoreactive (GFAP-ir) astrocytes in the hippocampus of Dx treated male rats. It showed that 21 days of Dx treatment (0.5mg/kg, i.p. once daily) significantly reduced the densities of cresyl violet positive neurons in the sub-areas CA1, CA3 and the dentate gyrus, but not in the CA2 area. However, CL pretreatment (100mg/kg, p.o.) was found to significantly restore neuronal densities in the CA1 and dentate gyrus. In addition, Dx treatment also significantly decreased the densities of the GFAP-ir astrocytes in the sub-areas CA1, CA3 and the dentate gyrus. However, CL pretreatment (100mg/kg, p.o.) failed to protect the loss of astrocytes in these sub-areas. These findings confirm the neuroprotective effects of the CL extract and indicate that the cause of astrocyte loss might be partially reduced by a non-oxidative mechanism. Moreover, the detection of neuronal and glial densities was suitable method to study brain damage and the effects of treatment.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Chronic stress; Cresyl violet; Curcuma longa; Dexamethasone; Glial fibrillary acidic protein; Hippocampus; Rats

Mesh:

Substances:

Year:  2014        PMID: 25440530     DOI: 10.1016/j.acthis.2014.09.009

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  4 in total

Review 1.  A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin.

Authors:  Shivkanya Fuloria; Jyoti Mehta; Aditi Chandel; Mahendran Sekar; Nur Najihah Izzati Mat Rani; M Yasmin Begum; Vetriselvan Subramaniyan; Kumarappan Chidambaram; Lakshmi Thangavelu; Rusli Nordin; Yuan Seng Wu; Kathiresan V Sathasivam; Pei Teng Lum; Dhanalekshmi Unnikrishnan Meenakshi; Vinoth Kumarasamy; Abul Kalam Azad; Neeraj Kumar Fuloria
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

Review 2.  Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along with the Most Effective Isolation Techniques and Type of Nanoformulations.

Authors:  Monica Butnariu; Cristina Quispe; Niranjan Koirala; Sujan Khadka; Carla Marina Salgado-Castillo; Muhammad Akram; Rabia Anum; Balakyz Yeskaliyeva; Natália Cruz-Martins; Miquel Martorell; Manoj Kumar; Radu Vasile Bagiu; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Javad Sharifi-Rad
Journal:  Int J Nanomedicine       Date:  2022-08-15

3.  Inhibition of HIV-1 by curcumin A, a novel curcumin analog.

Authors:  Namita Kumari; Amol A Kulkarni; Xionghao Lin; Charlee McLean; Tatiana Ammosova; Andrey Ivanov; Maria Hipolito; Sergei Nekhai; Evaristus Nwulia
Journal:  Drug Des Devel Ther       Date:  2015-09-03       Impact factor: 4.162

4.  Herbal composition of Cinnamomum cassia, Pinus densiflora, Curcuma longa and Glycyrrhiza glabra prevents atherosclerosis by upregulating p27 (Kip1) expression.

Authors:  Jung-Jin Lee; Ji-Hye Lee; Won-Kyung Cho; Joo-Hui Han; Jin Yeul Ma
Journal:  BMC Complement Altern Med       Date:  2016-07-28       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.